Cynata Therapeutics Limited ABN – 98 104 037 372 Level 3, 100 Cubitt Street Cremorne VIC 3121 Australia T: +613 7067 6940 E: [email protected] www.cynata.com cytl0001_2100021_218.docx ASX ANNOUNCEMENT 8 October 2026 Fully Underwritten Renounceable Entitlement Offer and Unmarketable Parcel Sale...
Entitlement Offer & Unmarketable Parcel Sale Facility
Filed with ASX · · 3 pages · English
Release
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Termination of At-the-Market Subscription Deed
- Cynata Receives R&D TI Refund & Repays R&D TI Loan
- R&D Tax Incentive Loan Facility Extension
- Date of AGM and Closing Date for Director Nominations
- Appendix 4G
Later from Cynata Therapeutics
- Proposed issue of securities - CYP
- Prospectus
- Target Market Determination
- Replacement Prospectus
- Replacement Target Market Determination
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics